Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Development ; 144(24): 4616-4624, 2017 12 15.
Article in English | MEDLINE | ID: mdl-29061637

ABSTRACT

During mammalian embryogenesis, cardiac progenitor cells constituting the second heart field (SHF) give rise to the right ventricle and primitive outflow tract (OFT). In zebrafish, previous lineage-tracing and mutant analyses suggested that SHF ventricular and OFT progenitors co-migrate to the arterial pole of the zebrafish heart tube soon after their specification in the nkx2.5+ field of anterior lateral plate mesoderm (ALPM). Using additional prospective lineage tracing, we demonstrate that while SHF ventricular progenitors migrate directly to the arterial pole, OFT progenitors become temporarily sequestered in the mesodermal cores of pharyngeal arch 2 (PA2), where they downregulate nkx2.5 expression. While there, they intermingle with precursors for PA2-derived head muscles (HMs) and hypobranchial artery endothelium, which we demonstrate are co-specified with SHF progenitors in the nkx2.5+ ALPM. Soon after their sequestration in PA2, OFT progenitors migrate to the arterial pole of the heart and differentiate into OFT lineages. Lastly, we demonstrate that SHF ventricular and OFT progenitors exhibit unique sensitivities to a mutation in fgf8a Our data highlight novel aspects of SHF, OFT and HM development in zebrafish that will inform mechanistic interpretations of cardiopharyngeal phenotypes in zebrafish models of human congenital disorders.


Subject(s)
Heart Defects, Congenital/embryology , Heart Ventricles/embryology , Stem Cells/cytology , Zebrafish/embryology , Animals , Branchial Region/metabolism , Cell Lineage , Cell Movement/physiology , Fibroblast Growth Factors/genetics , Gene Expression Regulation, Developmental , Heart Ventricles/metabolism , Homeobox Protein Nkx-2.5/biosynthesis , Mesoderm/metabolism , Myocardium/cytology , Myocardium/metabolism , Signal Transduction/genetics , Zebrafish/genetics , Zebrafish Proteins/biosynthesis , Zebrafish Proteins/genetics
2.
Development ; 143(1): 113-22, 2016 Jan 01.
Article in English | MEDLINE | ID: mdl-26732840

ABSTRACT

The vertebrate heart forms through successive phases of cardiomyocyte differentiation. Initially, cardiomyocytes derived from first heart field (FHF) progenitors assemble the linear heart tube. Thereafter, second heart field (SHF) progenitors differentiate into cardiomyocytes that are accreted to the poles of the heart tube over a well-defined developmental window. Although heart tube elongation deficiencies lead to life-threatening congenital heart defects, the variables controlling the initiation, rate and duration of myocardial accretion remain obscure. Here, we demonstrate that the AP-1 transcription factor, Fos-like antigen 2 (Fosl2), potentiates the rate of myocardial accretion from the zebrafish SHF. fosl2 mutants initiate accretion appropriately, but cardiomyocyte production is sluggish, resulting in a ventricular deficit coupled with an accumulation of SHF progenitors. Surprisingly, mutant embryos eventually correct the myocardial deficit by extending the accretion window. Overexpression of Fosl2 also compromises production of SHF-derived ventricular cardiomyocytes, a phenotype that is consistent with precocious depletion of the progenitor pool. Our data implicate Fosl2 in promoting the progenitor to cardiomyocyte transition and uncover the existence of regulatory mechanisms to ensure appropriate SHF-mediated cardiomyocyte contribution irrespective of embryonic stage.


Subject(s)
Cell Differentiation/physiology , Fos-Related Antigen-2/metabolism , Heart/embryology , Myocytes, Cardiac/cytology , Transcription Factor AP-1/metabolism , Zebrafish/embryology , Amino Acid Sequence , Animals , Animals, Genetically Modified , Cell Proliferation/genetics , Fos-Related Antigen-2/biosynthesis , Fos-Related Antigen-2/genetics , Gene Expression Regulation, Developmental , Gene Knockout Techniques , Heart Defects, Congenital/genetics , Myocardium/cytology , Sequence Analysis, Protein , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
3.
Development ; 140(6): 1353-63, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23444361

ABSTRACT

Second heart field (SHF) progenitors perform essential functions during mammalian cardiogenesis. We recently identified a population of cardiac progenitor cells (CPCs) in zebrafish expressing latent TGFß-binding protein 3 (ltbp3) that exhibits several defining characteristics of the anterior SHF in mammals. However, ltbp3 transcripts are conspicuously absent in anterior lateral plate mesoderm (ALPM), where SHF progenitors are specified in higher vertebrates. Instead, ltbp3 expression initiates at the arterial pole of the developing heart tube. Because the mechanisms of cardiac development are conserved evolutionarily, we hypothesized that zebrafish SHF specification also occurs in the ALPM. To test this hypothesis, we Cre/loxP lineage traced gata4(+) and nkx2.5(+) ALPM populations predicted to contain SHF progenitors, based on evolutionary conservation of ALPM patterning. Traced cells were identified in SHF-derived distal ventricular myocardium and in three lineages in the outflow tract (OFT). We confirmed the extent of contributions made by ALPM nkx2.5(+) cells using Kaede photoconversion. Taken together, these data demonstrate that, as in higher vertebrates, zebrafish SHF progenitors are specified within the ALPM and express nkx2.5. Furthermore, we tested the hypothesis that Nkx2.5 plays a conserved and essential role during zebrafish SHF development. Embryos injected with an nkx2.5 morpholino exhibited SHF phenotypes caused by compromised progenitor cell proliferation. Co-injecting low doses of nkx2.5 and ltbp3 morpholinos revealed a genetic interaction between these factors. Taken together, our data highlight two conserved features of zebrafish SHF development, reveal a novel genetic relationship between nkx2.5 and ltbp3, and underscore the utility of this model organism for deciphering SHF biology.


Subject(s)
Cell Differentiation , Heart Ventricles/embryology , Mesoderm/embryology , Stem Cells/physiology , Transcription Factors/physiology , Zebrafish Proteins/physiology , Zebrafish/embryology , Animals , Animals, Genetically Modified , Body Patterning/genetics , Body Patterning/physiology , Cell Differentiation/genetics , Cell Lineage/genetics , Cell Lineage/physiology , Embryo, Nonmammalian , Epistasis, Genetic/physiology , Gene Expression Regulation, Developmental/physiology , Heart/embryology , Heart/physiology , Heart Ventricles/metabolism , Homeobox Protein Nkx-2.5 , Latent TGF-beta Binding Proteins/genetics , Latent TGF-beta Binding Proteins/metabolism , Latent TGF-beta Binding Proteins/physiology , Mesoderm/metabolism , Mesoderm/physiology , Organ Specificity/genetics , Stem Cells/metabolism , Transcription Factors/genetics , Transcription Factors/metabolism , Zebrafish/genetics , Zebrafish/metabolism , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolism
4.
Curr Opin Cell Biol ; 16(6): 713-20, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15530786

ABSTRACT

Stem cells are defined by their capacity for self-renewal and multilineage differentiation, making them uniquely situated to treat a broad spectrum of human diseases. For example, because hematopoietic stem cells can reconstitute the entire blood system, bone marrow transplantation has long been used in the clinic to treat various diseases. Similarly, the transplantation of other tissue-specific stem cells, such as stem cells isolated from epithelial and neural tissues, can treat mouse disease models and human patients in which epithelial and neural cells are damaged. An alternative to tissue-specific stem cell therapy takes advantage of embryonic stem cells, which are capable of differentiating into any tissue type. Furthermore, nuclear transfer, the transfer of a post-mitotic somatic cell nucleus into an enucleated oocyte, creates a limitless source of autologous cells that, when combined with gene therapy, can serve as a powerful therapeutic tool.


Subject(s)
Hematopoietic Stem Cells/cytology , Neoplasms/therapy , Stem Cells/cytology , Stem Cells/physiology , Animals , Cell Nucleus/metabolism , Embryo, Mammalian/cytology , Epithelial Cells/cytology , Genetic Therapy/methods , Hematopoietic Stem Cells/physiology , Humans , Models, Biological , Neoplasms/pathology , Neurons/cytology , Stem Cell Transplantation
5.
PLoS Biol ; 2(8): E237, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15314655

ABSTRACT

Hematopoiesis is precisely orchestrated by lineage-specific DNA-binding proteins that regulate transcription in concert with coactivators and corepressors. Mutations in the zebrafish moonshine (mon) gene specifically disrupt both embryonic and adult hematopoiesis, resulting in severe red blood cell aplasia. We report that mon encodes the zebrafish ortholog of mammalian transcriptional intermediary factor 1gamma (TIF1gamma) (or TRIM33), a member of the TIF1 family of coactivators and corepressors. During development, hematopoietic progenitor cells in mon mutants fail to express normal levels of hematopoietic transcription factors, including gata1, and undergo apoptosis. Three different mon mutant alleles each encode premature stop codons, and enforced expression of wild-type tif1gamma mRNA rescues embryonic hematopoiesis in homozygous mon mutants. Surprisingly, a high level of zygotic tif1gamma mRNA expression delineates ventral mesoderm during hematopoietic stem cell and progenitor formation prior to gata1 expression. Transplantation studies reveal that tif1gamma functions in a cell-autonomous manner during the differentiation of erythroid precursors. Studies in murine erythroid cell lines demonstrate that Tif1gamma protein is localized within novel nuclear foci, and expression decreases during erythroid cell maturation. Our results establish a major role for this transcriptional intermediary factor in the differentiation of hematopoietic cells in vertebrates.


Subject(s)
Erythrocytes/pathology , Transcription Factors/genetics , Transcription Factors/physiology , Zebrafish Proteins/genetics , Zebrafish Proteins/physiology , Alleles , Animals , Apoptosis , Bone Marrow Transplantation , Cell Differentiation , Cell Line , Cell Nucleus/metabolism , Cell Survival , Cell Transplantation , Cloning, Molecular , Codon, Terminator , DNA/chemistry , DNA-Binding Proteins/chemistry , Erythrocytes/cytology , Gene Expression Regulation , Hematopoiesis , Hematopoietic Stem Cells/cytology , Heterochromatin/metabolism , Homozygote , Immunoblotting , Mice , Molecular Sequence Data , Mutation , Phenotype , Protein Binding , RNA, Messenger/metabolism , Transcription Factors/metabolism , Transcription, Genetic , Zebrafish , Zebrafish Proteins/chemistry
6.
Cell Rep ; 20(4): 973-983, 2017 07 25.
Article in English | MEDLINE | ID: mdl-28746880

ABSTRACT

The pharyngeal arch arteries (PAAs) are transient embryonic blood vessels that mature into critical segments of the aortic arch and its branches. Although defects in PAA development cause life-threating congenital cardiovascular defects, the molecular mechanisms that orchestrate PAA morphogenesis remain unclear. Through small-molecule screening in zebrafish, we identified TGF-ß signaling as indispensable for PAA development. Specifically, chemical inhibition of the TGF-ß type I receptor ALK5 impairs PAA development because nkx2.5+ PAA progenitor cells fail to differentiate into tie1+ angioblasts. Consistent with this observation, we documented a burst of ALK5-mediated Smad3 phosphorylation within PAA progenitors that foreshadows angioblast emergence. Remarkably, premature induction of TGF-ß receptor activity stimulates precocious angioblast differentiation, thereby demonstrating the sufficiency of this pathway for initiating the PAA progenitor to angioblast transition. More broadly, these data uncover TGF-ß as a rare signaling pathway that is necessary and sufficient for angioblast lineage commitment.


Subject(s)
Arteries/cytology , Branchial Region/blood supply , Transforming Growth Factor beta/metabolism , Zebrafish Proteins/metabolism , Animals , Homeobox Protein Nkx-2.5/genetics , Homeobox Protein Nkx-2.5/metabolism , Signal Transduction , Zebrafish , Zebrafish Proteins/genetics
7.
Methods Mol Med ; 105: 171-98, 2005.
Article in English | MEDLINE | ID: mdl-15492396

ABSTRACT

The zebrafish (Danio rerio) has emerged as a powerful vertebrate genetic and developmental model that is particularly amenable to the study of hematopoiesis. The zebrafish embryo develops externally and its optical clarity allows the number and morphology of circulating blood cells to be visualized using a dissecting microscope. Both the morphology of the blood lineages and the expression of critical blood genes are highly conserved between zebrafish and mammals. The high fecundity and short generation time of zebrafish facilitate genetic analysis, and a number of large-scale mutagenesis screens have identified mutations in genes affecting blood development. The discovery of novel hematopoietic genes, as well as the cloning of zebrafish homologs of known hematopoietic genes, necessitates the use of efficacious and reliable methods for complete gene characterization. In this chapter, we illustrate frequently used techniques that are essential for evaluating hematopoiesis in the zebrafish, including whole-mount in situ hybridization, the detection of erythrocytes by o-dianisidine staining, and a description of the microinjection procedure, which has various applications, including overexpression of messenger ribonucleic acid, gene "knockdown" by antisense technology, and the creation of transgenic zebrafish. Also included is an explanation of the use of flow cytometry to separate hematopoietic lineages from the adult kidney and to isolate relatively pure populations of cell types from transgenic embryos based on the expression of fluorescent markers.


Subject(s)
Cell Lineage/physiology , Gene Expression Regulation, Developmental/physiology , Gene Transfer Techniques , Hematopoiesis/physiology , Mutagenesis/genetics , Zebrafish/embryology , Animals , Animals, Genetically Modified , Cell Lineage/genetics , Gene Expression Regulation, Developmental/genetics , Hematopoiesis/genetics , Zebrafish/genetics
8.
Nat Cell Biol ; 15(11): 1362-9, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24161929

ABSTRACT

The pharyngeal arch arteries (PAAs) are transient embryonic blood vessels that make indispensable contributions to the carotid arteries and great vessels of the heart, including the aorta and pulmonary arteries. During embryogenesis, the PAAs appear in a craniocaudal sequence to connect pre-existing segments of the primitive circulation after de novo vasculogenic assembly from angioblast precursors. Despite the unique spatiotemporal characteristics of PAA development, the embryonic origins of PAA angioblasts and the genetic factors regulating their emergence remain unknown. Here, we identify the embryonic source of PAA endothelium as nkx2.5(+) progenitors in lateral plate mesoderm long considered to adopt cell fates within the heart exclusively. Further, we report that PAA endothelial differentiation relies on Nkx2.5, a canonical cardiac transcription factor not previously implicated in blood vessel formation. Together, these studies reveal the heart field origin of PAA endothelium and attribute a new vasculogenic function to the cardiac transcription factor Nkx2.5 during great vessel precursor development.


Subject(s)
Blood Vessels/embryology , Gene Expression Regulation, Developmental , Heart/embryology , Transcription Factors/genetics , Zebrafish Proteins/genetics , Zebrafish/embryology , Animals , Homeobox Protein Nkx-2.5
9.
Blood ; 110(7): 2718-26, 2007 Oct 01.
Article in English | MEDLINE | ID: mdl-17579187

ABSTRACT

Erythropoietin (Epo) and its cognate receptor (EpoR) are required for maintaining adequate levels of circulating erythrocytes during embryogenesis and adulthood. Here, we report the functional characterization of the zebrafish epo and epor genes. The expression of epo and epor was evaluated by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and whole-mount in situ hybridization, revealing marked parallels between zebrafish and mammalian gene expression patterns. Examination of the hypochromic mutant, weissherbst, and adult hypoxia-treated hearts indicate that zebrafish epo expression is induced by anemia and hypoxia. Overexpression of epo mRNA resulted in severe polycythemia, characterized by a striking increase in the number of cells expressing scl, c-myb, gata1, ikaros, epor, and betae1-globin, suggesting that both the erythroid progenitor and mature erythrocyte compartments respond to epo. Morpholino-mediated knockdown of the epor caused a slight decrease in primitive and complete block of definitive erythropoiesis. Abrogation of STAT5 blocked the erythropoietic expansion by epo mRNA, consistent with a requirement for STAT5 in epo signaling. Together, the characterization of zebrafish epo and epor demonstrates the conservation of an ancient program that ensures proper red blood cell numbers during normal homeostasis and under hypoxic conditions.


Subject(s)
Erythropoietin/metabolism , Signal Transduction , Zebrafish/metabolism , Amino Acid Sequence , Anemia/metabolism , Anemia/pathology , Animals , Conserved Sequence , DNA, Complementary/genetics , Embryo, Nonmammalian/cytology , Embryo, Nonmammalian/embryology , Embryo, Nonmammalian/metabolism , Erythroid Cells/cytology , Erythropoiesis , Erythropoietin/chemistry , Erythropoietin/genetics , Erythropoietin/isolation & purification , Gene Expression Regulation, Developmental , Humans , Hypoxia/metabolism , Hypoxia/pathology , Molecular Sequence Data , Receptors, Erythropoietin/chemistry , Receptors, Erythropoietin/genetics , Receptors, Erythropoietin/metabolism , STAT5 Transcription Factor/metabolism , Sequence Alignment , Zebrafish/embryology , Zebrafish/genetics
10.
Blood ; 106(2): 521-30, 2005 Jul 15.
Article in English | MEDLINE | ID: mdl-15827125

ABSTRACT

Hematopoiesis involves the production of stem cells, followed by the orchestrated differentiation of the blood lineages. Genetic screens in zebrafish have identified mutants with defects that disrupt specific stages of hematopoiesis and vasculogenesis, including the cloche, spadetail (tbx16), moonshine (tif1g), bloodless, and vlad tepes (gata1) mutants. To better characterize the blood program, gene expression profiling was carried out in these mutants and in scl-morphants (scl(mo)). Distinct gene clusters were demarcated by stage-specific and mutant-specific gene regulation. These were found to correlate with the transcriptional program of hematopoietic progenitor cells, as well as of the erythroid, myeloid, and vascular lineages. Among these, several novel hematopoietic and vascular genes were detected, for instance, the erythroid transcription factors znfl2 and ncoa4. A specific regulation was found for myeloid genes, as they were more strongly expressed in vlt mutants compared with other erythroid mutants. A unique gene expression pattern of up-regulated isoprenoid synthesis genes was found in cloche and scl(mo), possibly in migrating cells. In conjunction with the high conservation of vertebrate hematopoiesis, the comparison of transcriptional profiles in zebrafish blood mutants represents a versatile and powerful tool to elucidate the genetic regulation of blood and blood vessel development.


Subject(s)
Hematopoiesis/genetics , Mutation , Zebrafish/embryology , Zebrafish/genetics , Animals , Blood Vessels/embryology , Erythropoiesis/genetics , Gene Expression Profiling , Gene Expression Regulation, Developmental , In Situ Hybridization , Multigene Family , Myelopoiesis/genetics , Phenotype , Transcription, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL